DENTSPLY SIRONA (XRAY) Competitors

DENTSPLY SIRONA (NASDAQ:XRAY) and Envista (NYSE:NVST) are both mid-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, media sentiment, community ranking, analyst recommendations, risk, profitability and earnings.

Do analysts rate XRAY or NVST?

DENTSPLY SIRONA presently has a consensus price target of $39.50, indicating a potential upside of 29.21%. Envista has a consensus price target of $27.90, indicating a potential upside of 36.83%. Given Envista's higher probable upside, analysts plainly believe Envista is more favorable than DENTSPLY SIRONA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DENTSPLY SIRONA	0 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.67
Envista	3 Sell rating(s)	6 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.91

Is XRAY or NVST more profitable?

DENTSPLY SIRONA has a net margin of -3.33% compared to Envista's net margin of -3.90%. DENTSPLY SIRONA's return on equity of 11.14% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DENTSPLY SIRONA	-3.33%	11.14%	5.22%
Envista	-3.90%	6.31%	4.07%

Does the MarketBeat Community prefer XRAY or NVST?

DENTSPLY SIRONA received 426 more outperform votes than Envista when rated by MarketBeat users. Likewise, 61.38% of users gave DENTSPLY SIRONA an outperform vote while only 40.30% of users gave Envista an outperform vote.

Company	Underperform	Outperform
DENTSPLY SIRONA	Outperform Votes 453 61.38%	Underperform Votes 285 38.62%
Envista	Outperform Votes 27 40.30%	Underperform Votes 40 59.70%

Do insiders & institutionals have more ownership in XRAY or NVST?

95.7% of DENTSPLY SIRONA shares are owned by institutional investors. 0.7% of DENTSPLY SIRONA shares are owned by insiders. Comparatively, 1.3% of Envista shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Which has more risk and volatility, XRAY or NVST?

DENTSPLY SIRONA has a beta of 0.98, meaning that its stock price is 2% less volatile than the S&P 500. Comparatively, Envista has a beta of 1.35, meaning that its stock price is 35% more volatile than the S&P 500.

Which has better earnings and valuation, XRAY or NVST?

Envista has lower revenue, but higher earnings than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DENTSPLY SIRONA	$3.97B	1.60	-$132M	-$0.62	-49.31
Envista	$2.57B	1.37	-$100.20M	-$0.61	-33.43

Does the media favor XRAY or NVST?

In the previous week, Envista had 4 more articles in the media than DENTSPLY SIRONA. MarketBeat recorded 10 mentions for Envista and 6 mentions for DENTSPLY SIRONA. Envista's average media sentiment score of 0.86 beat DENTSPLY SIRONA's score of 0.85 indicating that Envista is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DENTSPLY SIRONA	3 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Envista	6 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

DENTSPLY SIRONA beats Envista on 10 of the 18 factors compared between the two stocks.